Quick Answer
BIOGEN INC. reported Total Assets of $29.44 billion for fiscal year 2025.
BIOGEN INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $29.44B | +5.0% |
| 2024 | $28.05B | +4.5% |
| 2023 | $26.84B | +9.3% |
| 2022 | $24.55B | +2.8% |
| 2021 | $23.88B | -3.0% |
| 2020 | $24.62B | -9.6% |
| 2019 | $27.23B | +7.7% |
| 2018 | $25.29B | +6.9% |
| 2017 | $23.65B | +3.4% |
| 2016 | $22.88B | +17.3% |
| 2015 | $19.50B | +36.3% |
| 2014 | $14.31B | +20.7% |
| 2013 | $11.86B | +17.1% |
| 2012 | $10.13B | +11.9% |
| 2011 | $9.05B | +11.8% |
| 2010 | $8.09B | -5.4% |
| 2009 | $8.55B | +0.9% |
| 2008 | $8.48B | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $29.21B | +3.2% | +3.1% |
| June 30, 2025 | $28.33B | +5.7% | +1.1% |
| March 31, 2025 | $28.03B | +5.5% | -0.1% |
| December 31, 2024 | $28.05B | +4.5% | -0.9% |
| September 30, 2024 | $28.31B | +0.4% | +5.6% |
| June 30, 2024 | $26.80B | +6.5% | +0.9% |
| March 31, 2024 | $26.57B | +8.0% | -1.0% |
| December 31, 2023 | $26.84B | +9.3% | -4.8% |
- BIOGEN INC. showed an increase of +5.0% in Total Assets compared to the prior fiscal year.
- Over the 2008–2025 period, BIOGEN INC.’s total assets has grown by 247.2% (from $8.48 billion to $29.44 billion).
- The most recent figure is from BIOGEN INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: